Examine the data and tweets to deduce if the closing price of $mrk will boost or lower at 2017-09-14. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-08-30,0.0,0.1,-0.3,0.0,0.0,-0.1,-1.0,-1.0,-0.8,-0.5,-0.6
2017-08-31,-0.8,0.1,-1.4,1.2,1.2,-0.9,-1.8,-2.0,-2.0,-1.6,-1.7
2017-09-01,-0.1,0.4,-0.4,-0.0,-0.0,-0.6,-1.4,-1.8,-1.9,-1.6,-1.5
2017-09-05,0.2,0.8,-0.3,-0.3,-0.3,-0.2,-0.8,-1.3,-1.5,-1.3,-1.2
2017-09-06,-0.2,0.5,-0.4,0.6,0.6,-0.5,-1.1,-1.8,-1.9,-1.8,-1.7
2017-09-07,-0.4,0.2,-0.8,0.5,0.5,-0.6,-1.3,-2.1,-2.3,-2.3,-2.0
2017-09-08,-0.4,0.4,-0.5,-0.1,-0.1,-0.4,-1.0,-1.8,-2.0,-2.2,-1.9
2017-09-11,-0.3,0.3,-0.7,1.3,1.3,-1.3,-2.0,-2.7,-3.1,-3.3,-3.2
2017-09-12,-0.5,0.2,-0.5,0.5,0.5,-1.3,-2.1,-2.8,-3.4,-3.6,-3.6
2017-09-13,-0.1,0.2,-0.2,-0.0,-0.0,-0.8,-1.7,-2.5,-3.2,-3.4,-3.5

2017-08-30: rt AT_USER $incy $mrk epacadostat/keytruda melanoma (echo-202 study) update looks good ¡ª&gt; |$halo (hyaluronidase) with cancer drugs, is like lemon (citric acid) with water/tea. increases absorption
2017-08-31: fda issues warning about testing merck's keytruda in multiple myeloma  $mrk #cancer #pharma #biotech #keytruda #fda|$mrk top stock reports for merck, caterpillar &amp; intel now on |investors are bett
2017-09-01: s&amp;p100 #stocks trend $gd $msft $cat $fdx $pcln $intc $ups $foxa $mrk $cmcsa $hal $dow $dd $t $emr $usb $all  @ |dow #stocks trend $msft $cat $intc $mrk $dd $ba $csco $aapl $ibm $mcd $jpm $dis $unh
2017-09-02: rt AT_USER key fda/ema regulatory catalysts next 2 months sept/oct $mrk $ptct $tsro $flxn $alxn $acrx $ibb |merck &amp; company, inc. $mrk receives ¡°hold¡± rating from cowen and company |merck &amp; 
2017-09-03: rt AT_USER key fda/ema regulatory catalysts next 2 months sept/oct $mrk $ptct $tsro $flxn $alxn $acrx $ibb |rt AT_USER key fda/ema regulatory catalysts next 2 months sept/oct $mrk $ptct $tsro $flxn $a
2017-09-04: #allergan ceo on guidance! $agn $myl $mrk $msft $goog $fb $amzn $crm $cmg $brk $iep $hlf $ko $pep $twtr $f $ba $ge¡­ |will the bold #allergan volunteer &amp; be a leader or will they wait until regula
2017-09-05: $oncs ah price up 6% and climbing. new hire happens to have been in charge of m&amp;a's. lol if you can't read between the lines $bmy $mrk|credit suisse reiterated merck &amp; $mrk at outperform. cash
2017-09-06: gilead $gild to acquire kite pharma $kite for $11.9 billion ! $juno $insm $sprt $biib $otic $vygr $arna $cpxx $kerx $lly $mrk $jnj $exas|rt AT_USER following recent $mrk pembro news fda has placed par
2017-09-07: this could be driving merck's valuation after 2q17  $mrk $pfe $lly $nvs|rt AT_USER vantage snippet - keytruda¡¯s multiple myeloma fallout has roche in the firing line $mrk $bmy $azn $rhhby |$mrk is in
2017-09-08: eow paper trade updates: resistance at $160 is holding for $cost and $mrk hovering around $64 - still early though - plenty of time to fail!|do you see $agn stock trading hault today as a stock manipu
2017-09-09: AT_USER AT_USER AT_USER life saving tech developed by $mrk, $pfe, $jnj, $gild, $mon, $agu, and $de r¡­ |rt AT_USER zepatier ex-us sales continuing to climb ($261m) as $mrk aggressive discounting is ta
2017-09-10: merck &amp; company, inc. $mrk receives $69.40 average price target from brokerages |in atlanta, i hope my roof &amp; electricity holds out! $twtr $aapl $brk $iep $amzn $goog $agn $myl $mrk $f $ba $aa
2017-09-11: big call buyers  $gt $pgr $ati $home $adm $paa $twlo $amd $bac $oc $tgt $mrk $jpm $kgc $shpg $tlt $eem $xlf|rt AT_USER winners in melanoma $bmy $arry $nvs $mrk $incy AT_USER |AT_USER thxfor follow! vi
2017-09-12: $qqq $tqqq $mrk $amzn $goog  - do you like these recommendations from marc m |big call buyers  $nov $afl $icpt $snap $do $cvs $expr $payx $swn $vnet $abt $mrk $kr $ual $fast $lite $mdlz $xrt|no debt b
2017-09-13: shkreli gets maximum security prison! $vrx $mnk $goog $ko $twtr $fold $amzn $ko $pep $jazz $amgn $myl $mrk $crm¡­ |rt AT_USER event ¨c the next showdown in first-line lung cancer  $rhhby $bmy $mrk $az
Answer:
Examine the data and tweets to deduce if the closing price of $mrk will boost or lower at 2017-09-14. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-08-30,0.0,0.1,-0.3,0.0,0.0,-0.1,-1.0,-1.0,-0.8,-0.5,-0.6
2017-08-31,-0.8,0.1,-1.4,1.2,1.2,-0.9,-1.8,-2.0,-2.0,-1.6,-1.7
2017-09-01,-0.1,0.4,-0.4,-0.0,-0.0,-0.6,-1.4,-1.8,-1.9,-1.6,-1.5
2017-09-05,0.2,0.8,-0.3,-0.3,-0.3,-0.2,-0.8,-1.3,-1.5,-1.3,-1.2
2017-09-06,-0.2,0.5,-0.4,0.6,0.6,-0.5,-1.1,-1.8,-1.9,-1.8,-1.7
2017-09-07,-0.4,0.2,-0.8,0.5,0.5,-0.6,-1.3,-2.1,-2.3,-2.3,-2.0
2017-09-08,-0.4,0.4,-0.5,-0.1,-0.1,-0.4,-1.0,-1.8,-2.0,-2.2,-1.9
2017-09-11,-0.3,0.3,-0.7,1.3,1.3,-1.3,-2.0,-2.7,-3.1,-3.3,-3.2
2017-09-12,-0.5,0.2,-0.5,0.5,0.5,-1.3,-2.1,-2.8,-3.4,-3.6,-3.6
2017-09-13,-0.1,0.2,-0.2,-0.0,-0.0,-0.8,-1.7,-2.5,-3.2,-3.4,-3.5

2017-08-30: rt AT_USER $incy $mrk epacadostat/keytruda melanoma (echo-202 study) update looks good ¡ª&gt; |$halo (hyaluronidase) with cancer drugs, is like lemon (citric acid) with water/tea. increases absorption
2017-08-31: fda issues warning about testing merck's keytruda in multiple myeloma  $mrk #cancer #pharma #biotech #keytruda #fda|$mrk top stock reports for merck, caterpillar &amp; intel now on |investors are bett
2017-09-01: s&amp;p100 #stocks trend $gd $msft $cat $fdx $pcln $intc $ups $foxa $mrk $cmcsa $hal $dow $dd $t $emr $usb $all  @ |dow #stocks trend $msft $cat $intc $mrk $dd $ba $csco $aapl $ibm $mcd $jpm $dis $unh
2017-09-02: rt AT_USER key fda/ema regulatory catalysts next 2 months sept/oct $mrk $ptct $tsro $flxn $alxn $acrx $ibb |merck &amp; company, inc. $mrk receives ¡°hold¡± rating from cowen and company |merck &amp; 
2017-09-03: rt AT_USER key fda/ema regulatory catalysts next 2 months sept/oct $mrk $ptct $tsro $flxn $alxn $acrx $ibb |rt AT_USER key fda/ema regulatory catalysts next 2 months sept/oct $mrk $ptct $tsro $flxn $a
2017-09-04: #allergan ceo on guidance! $agn $myl $mrk $msft $goog $fb $amzn $crm $cmg $brk $iep $hlf $ko $pep $twtr $f $ba $ge¡­ |will the bold #allergan volunteer &amp; be a leader or will they wait until regula
2017-09-05: $oncs ah price up 6% and climbing. new hire happens to have been in charge of m&amp;a's. lol if you can't read between the lines $bmy $mrk|credit suisse reiterated merck &amp; $mrk at outperform. cash
2017-09-06: gilead $gild to acquire kite pharma $kite for $11.9 billion ! $juno $insm $sprt $biib $otic $vygr $arna $cpxx $kerx $lly $mrk $jnj $exas|rt AT_USER following recent $mrk pembro news fda has placed par
2017-09-07: this could be driving merck's valuation after 2q17  $mrk $pfe $lly $nvs|rt AT_USER vantage snippet - keytruda¡¯s multiple myeloma fallout has roche in the firing line $mrk $bmy $azn $rhhby |$mrk is in
2017-09-08: eow paper trade updates: resistance at $160 is holding for $cost and $mrk hovering around $64 - still early though - plenty of time to fail!|do you see $agn stock trading hault today as a stock manipu
2017-09-09: AT_USER AT_USER AT_USER life saving tech developed by $mrk, $pfe, $jnj, $gild, $mon, $agu, and $de r¡­ |rt AT_USER zepatier ex-us sales continuing to climb ($261m) as $mrk aggressive discounting is ta
2017-09-10: merck &amp; company, inc. $mrk receives $69.40 average price target from brokerages |in atlanta, i hope my roof &amp; electricity holds out! $twtr $aapl $brk $iep $amzn $goog $agn $myl $mrk $f $ba $aa
2017-09-11: big call buyers  $gt $pgr $ati $home $adm $paa $twlo $amd $bac $oc $tgt $mrk $jpm $kgc $shpg $tlt $eem $xlf|rt AT_USER winners in melanoma $bmy $arry $nvs $mrk $incy AT_USER |AT_USER thxfor follow! vi
2017-09-12: $qqq $tqqq $mrk $amzn $goog  - do you like these recommendations from marc m |big call buyers  $nov $afl $icpt $snap $do $cvs $expr $payx $swn $vnet $abt $mrk $kr $ual $fast $lite $mdlz $xrt|no debt b
2017-09-13: shkreli gets maximum security prison! $vrx $mnk $goog $ko $twtr $fold $amzn $ko $pep $jazz $amgn $myl $mrk $crm¡­ |rt AT_USER event ¨c the next showdown in first-line lung cancer  $rhhby $bmy $mrk $az
Answer:+Rise